{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:31:55Z","timestamp":1787581915939,"version":"build-2736575974"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22501245"],"award-info":[{"award-number":["22501245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2023ZD0121002"],"award-info":[{"award-number":["2023ZD0121002"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115065","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:24:35Z","timestamp":1780417475000},"page":"115065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immune cell delivery platforms for tumor therapy: From empirical approaches to AI-integrated frameworks"],"prefix":"10.1016","volume":"396","author":[{"given":"Hao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115065_bb0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10555-010-9236-1","article-title":"Cancer and metastasis: prevention and treatment by green tea","volume":"29","author":"Khan","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jconrel.2026.115065_bb0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-025-01967-4","article-title":"Targeting NAD+biosynthesis suppresses TGF-\u03b21\/smads\/RAB26 axis and potentiates cisplatin cytotoxicity in non-small cell lung cancer brain metastasis","volume":"13","author":"Zhou","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jconrel.2026.115065_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2022.10.006","article-title":"Mechanisms of cancer metastasis","volume":"87","author":"Castaneda","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0020","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115065_bb0025","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115065_bb0030","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115065_bb0035","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA-Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.115065_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA-Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.115065_bb0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0050","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41556-024-01409-8","article-title":"Cell-intrinsic and microenvironmental determinants of metastatic colonization","volume":"26","author":"Lambert","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0055","first-page":"1","article-title":"Invasion and metastasis in cancer: molecular insights and therapeutic targets","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115065_bb0060","doi-asserted-by":"crossref","first-page":"13311","DOI":"10.3390\/ijms222413311","article-title":"Immune regulatory processes of the tumor microenvironment under malignant conditions","volume":"22","author":"Pansy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115065_bb0065","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41556-022-00969-x","article-title":"Untangling the web of intratumour heterogeneity","volume":"24","author":"Li","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0070","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1039\/D2CS00968D","article-title":"Immunological nanomaterials to combat cancer metastasis","volume":"53","author":"Pan","year":"2024","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.115065_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115065_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1260825","article-title":"Variation in cancer risk among tissues can be explained by the number of stem cell divisions","volume":"347","author":"Tomasetti","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115065_bb0085","doi-asserted-by":"crossref","first-page":"1442888","DOI":"10.3389\/fphar.2024.1442888","article-title":"Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications","volume":"15","author":"Biray Avci","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0090","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1038\/s41467-023-41335-1","article-title":"A cytotoxic T cell inspired oncolytic nanosystem promotes lytic cell death by lipid peroxidation and elicits antitumor immune responses","volume":"14","author":"Zuo","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115065_bb0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.20517\/cs.2022.45","article-title":"Host-guest assemblies for improved photothermal cancer therapy","volume":"3","author":"Sun","year":"2023","journal-title":"Chem. Synth."},{"key":"10.1016\/j.jconrel.2026.115065_bb0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037424","article-title":"The immune microenvironment and cancer metastasis","volume":"10","author":"El-Kenawi","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111875","article-title":"Recent advances in regenerative medicine strategies for cancer treatment","volume":"141","author":"Mansouri","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.115065_bb0110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jamaoncol.2018.4224","article-title":"Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-negative breast cancer: a phase 1 study","volume":"5","author":"Emens","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0115","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1038\/s41467-024-52528-7","article-title":"Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial","volume":"15","author":"Baretti","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115065_bb0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb0125","article-title":"Role of immunotherapy in the treatment of triple-negative breast cancer: a literature review","volume":"14","author":"Patel","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jconrel.2026.115065_bb0130","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.trecan.2021.02.003","article-title":"Next generation immunotherapies for brain metastatic cancers","volume":"7","author":"V\u00e1zquez","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2026.115065_bb0135","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3390\/ijms20112767","article-title":"TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis","volume":"20","author":"Hao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115065_bb0140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115065_bb0145","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115065_bb0155","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.tcb.2015.07.012","article-title":"Epithelial\u2013Mesenchymal plasticity: a central regulator of cancer progression","volume":"25","author":"Ye","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","article-title":"Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response","volume":"14","author":"Fu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0165","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0170","article-title":"Immunotherapy: reshape the tumor immune microenvironment","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0175","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jconrel.2024.09.037","article-title":"New avenues for cancer immunotherapy: cell-mediated drug delivery systems","volume":"375","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115065_bb0180","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036863","article-title":"New approaches on cancer immunotherapy","volume":"10","author":"Cha","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1612","article-title":"Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy","volume":"12","author":"Yang","year":"2020","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0190","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1016\/j.apsb.2022.11.001","article-title":"Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy","volume":"12","author":"Xu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115065_bb0195","first-page":"1138","article-title":"Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer","volume":"4","author":"Zheng","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.115065_bb0200","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41551-021-00712-1","article-title":"Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets","volume":"5","author":"Hu","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115065_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2022.07.004","article-title":"Correlation between PD-1\/PD-L1 expression and polarization in tumor-associated macrophages: a key player in tumor immunotherapy","volume":"67","author":"Li","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2026.115065_bb0210","doi-asserted-by":"crossref","first-page":"2401384","DOI":"10.1002\/adma.202401384","article-title":"A T-cell inspired sonoporation system enhances low-dose X-ray-mediated pyroptosis and radioimmunotherapy efficacy by restoring gasdermin-E expression","volume":"36","author":"Yin","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0215","doi-asserted-by":"crossref","first-page":"2205166","DOI":"10.1002\/smll.202205166","article-title":"Cell-based drug delivery systems participate in the cancer immunity cycle for improved cancer immunotherapy","volume":"19","author":"Fan","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115065_bb0220","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1021\/acsnano.3c11445","article-title":"Systemic delivery of paclitaxel by find-me nanoparticles activates antitumor immunity and eliminates tumors","volume":"18","author":"Kwon","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0225","doi-asserted-by":"crossref","first-page":"17554","DOI":"10.1021\/acsnano.3c06733","article-title":"Enhanced local delivery of engineered IL-2 mRNA by porous silica nanoparticles to promote effective antitumor immunity","volume":"17","author":"Shin","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0230","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1021\/acsnano.8b00081","article-title":"Self-assembled peptide\u2013lanthanide nanoclusters for safe tumor therapy: overcoming and utilizing biological barriers to peptide drug delivery","volume":"12","author":"Yan","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0235","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","article-title":"Cancer treatment therapies: traditional to modern approaches to combat cancers","volume":"50","author":"Kaur","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jconrel.2026.115065_bb0240","doi-asserted-by":"crossref","first-page":"1700818","DOI":"10.1002\/adhm.201700818","article-title":"Cell-based drug delivery and use of nano-and microcarriers for cell functionalization","volume":"7","author":"Timin","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0245","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12951-022-01287-y","article-title":"Biomimetic nanoprobe-augmented triple therapy with photothermal, sonodynamic and checkpoint blockade inhibits tumor growth and metastasis","volume":"20","author":"Lin","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0250","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1097\/CM9.0000000000002525","article-title":"Tumor immune microenvironment-modulated nanostrategy for the treatment of lung cancer metastasis","volume":"136","author":"Zhu","year":"2023","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jconrel.2026.115065_bb0255","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1021\/acsnano.3c11260","article-title":"Nanotechnology reprogramming metabolism for enhanced tumor immunotherapy","volume":"18","author":"Zhou","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0260","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.cclet.2021.10.074","article-title":"Applying nanotechnology to boost cancer immunotherapy by promoting immunogenic cell death","volume":"33","author":"Fu","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.115065_bb0265","doi-asserted-by":"crossref","first-page":"2111670","DOI":"10.1002\/adfm.202111670","article-title":"Understanding structure\u2013function relationships of nanoadjuvants for enhanced cancer vaccine efficacy","volume":"32","author":"Tan","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0270","first-page":"69","article-title":"CAR-T cell therapy: current limitations and potential strategies, blood","volume":"11","author":"Sterner","year":"2021","journal-title":"Cancer J."},{"key":"10.1016\/j.jconrel.2026.115065_bb0275","doi-asserted-by":"crossref","first-page":"2309839","DOI":"10.1002\/adma.202309839","article-title":"A CTL-inspired killing system using ultralow-dose chemical-drugs to induce a pyroptosis-mediated antitumor immune function","volume":"36","author":"Yin","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0280","doi-asserted-by":"crossref","first-page":"2305934","DOI":"10.1002\/advs.202305934","article-title":"A bioinspired immunostimulatory system for inducing powerful antitumor immune function by directly causing plasma membrane rupture","volume":"11","author":"Hu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115065_bb0285","doi-asserted-by":"crossref","first-page":"2410336","DOI":"10.1002\/advs.202410336","article-title":"Pyroptosis-inducing biomaterials pave the way for transformative antitumor immunotherapy","volume":"11","author":"Yin","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115065_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2022.110981","article-title":"Strategic combinatorial delivery of tranilast and paclitaxel using differently functionalized PLGA nanoparticles for enhanced penetration and accumulation in breast tumor","volume":"169","author":"Famta","year":"2022","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jconrel.2026.115065_bb0295","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","article-title":"Engineering the next generation of cell-based therapeutics","volume":"21","author":"Bashor","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115065_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/cac2.70053","article-title":"Harnessing chimeric antigen receptor macrophages against solid tumors","author":"Wang","year":"2025","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jconrel.2026.115065_bb0305","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.apsb.2025.09.022","article-title":"Artificial intelligence for drug delivery: yesterday, today and tomorrow","volume":"16","author":"Wu","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115065_bb0310","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41568-025-00796-w","article-title":"Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer","volume":"25","author":"Harkos","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115065_bb0315","first-page":"24","article-title":"AI-driven approaches to stem cell therapy in cancer: innovations and challenges","volume":"2","author":"Saki","year":"2025","journal-title":"Int. J. BioMed Insights"},{"key":"10.1016\/j.jconrel.2026.115065_bb0320","series-title":"Next-Generation Drug Delivery Systems","year":"2025"},{"key":"10.1016\/j.jconrel.2026.115065_bb0325","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/pharmaceutics17080992","article-title":"Artificial intelligence-driven strategies for targeted delivery and enhanced stability of RNA-based lipid nanoparticle cancer vaccines","volume":"17","author":"Bhujel","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115065_bb0330","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2174\/0115680266324522240725053634","article-title":"Impact of artificial intelligence on drug development and delivery","volume":"25","author":"Aundhia","year":"2025","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115065_bb0335","doi-asserted-by":"crossref","first-page":"2407793","DOI":"10.1002\/adma.202407793","article-title":"Toward the integration of machine learning and molecular modeling for designing drug delivery nanocarriers","volume":"36","author":"Gao","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0340","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.adv0422","article-title":"De novo-designed pMHC binders facilitate T cell\u2013mediated cytotoxicity toward cancer cells","volume":"389","author":"Johansen","year":"2025","journal-title":"Science"},{"issue":"2023","key":"10.1016\/j.jconrel.2026.115065_bb0345","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMra2302038","article-title":"Artificial intelligence and machine learning in clinical medicine","volume":"388","author":"Haug","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb0350","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.aat2663","article-title":"Inverse molecular design using machine learning: generative models for matter engineering","volume":"361","author":"Sanchez-Lengeling","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115065_bb0355","first-page":"1","article-title":"Reimagining human-centric drug development with new approach methodologies","author":"Wu","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115065_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2023.1216585","article-title":"Machine learning-based integration develops a neutrophil-derived signature for improving outcomes in hepatocellular carcinoma","volume":"14","author":"Gong","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0365","first-page":"1","article-title":"Applications of artificial intelligence in cancer immunotherapy: a frontier review on enhancing treatment efficacy and safety","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0370","first-page":"1","article-title":"Machine learning reshapes the paradigm of nanomedicine research","author":"Wei","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115065_bb0375","doi-asserted-by":"crossref","first-page":"1805557","DOI":"10.1002\/adma.201805557","article-title":"Nanoparticle-laden macrophages for tumor-tropic drug delivery","volume":"30","author":"Zhang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0380","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6579","article-title":"Cellular backpacks for macrophage immunotherapy","volume":"6","author":"Shields","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115065_bb0385","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1038\/s41467-021-24564-0","article-title":"Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115065_bb0390","doi-asserted-by":"crossref","first-page":"2102440","DOI":"10.1002\/adfm.202102440","article-title":"Supramolecular macrophage-liposome marriage for cell-hitchhiking delivery and immunotherapy of acute pneumonia and melanoma","volume":"31","author":"Gao","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0395","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0400","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jconrel.2022.12.001","article-title":"A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy","volume":"353","author":"Wen","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115065_bb0405","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12951-023-02122-8","article-title":"Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles","volume":"21","author":"Chong","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0410","doi-asserted-by":"crossref","first-page":"23746","DOI":"10.1021\/acsnano.3c07555","article-title":"Biomimetic macrophage membrane-camouflaged nanoparticles induce ferroptosis by promoting mitochondrial damage in glioblastoma","volume":"17","author":"Cao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0415","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","article-title":"Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer","volume":"10","author":"Cao","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0420","doi-asserted-by":"crossref","first-page":"12544","DOI":"10.1039\/C5NR07796F","article-title":"Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions","volume":"8","author":"Leonard","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115065_bb0425","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1021\/acs.nanolett.7b02330","article-title":"Inflammatory monocytes loading protease-sensitive nanoparticles enable lung metastasis targeting and intelligent drug release for anti-metastasis therapy","volume":"17","author":"He","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115065_bb0430","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1021\/acs.nanolett.8b01236","article-title":"Bioengineered macrophages can responsively transform into nanovesicles to target lung metastasis","volume":"18","author":"Cao","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115065_bb0435","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.omtn.2019.04.016","article-title":"Targeting lymph node sinus macrophages to inhibit lymph node metastasis","volume":"16","author":"Hu","year":"2019","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115065_bb0440","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/jacs.9b11046","article-title":"In vivo monocyte\/macrophage-hitchhiked intratumoral accumulation of nanomedicines for enhanced tumor therapy","volume":"142","author":"Zheng","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115065_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120670","article-title":"In situ poly I:C released from living cell drug nanocarriers for macrophage-mediated antitumor immunotherapy","volume":"269","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115065_bb0450","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1021\/acsami.1c22432","article-title":"Macrophage-mimic hollow mesoporous Fe-based nanocatalysts for self-amplified chemodynamic therapy and metastasis inhibition via tumor microenvironment remodeling","volume":"14","author":"Zuo","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115065_bb0455","doi-asserted-by":"crossref","first-page":"2207488","DOI":"10.1002\/advs.202207488","article-title":"Systemic tumor suppression via macrophage-driven automated homing of metal-phenolic-gated nanosponges for metastatic melanoma","volume":"10","author":"Liao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115065_bb0460","doi-asserted-by":"crossref","first-page":"2305526","DOI":"10.1002\/smll.202305526","article-title":"Macrophages-based biohybrid microrobots for breast cancer photothermal immunotherapy by inducing pyroptosis","volume":"20","author":"Xing","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115065_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.128217","article-title":"Synergistic ferroptosis and macrophage re-polarization using engineering exosome-mimic M1 nanovesicles for cancer metastasis suppression","volume":"409","author":"Li","year":"2021","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.115065_bb0470","doi-asserted-by":"crossref","first-page":"2405061","DOI":"10.1002\/adhm.202405061","article-title":"Ultrasonic cavitation-manipulated macrophages hitchhiking augments delivery of nanocarriers for active and efficient cancer therapy","author":"Shen","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0475","doi-asserted-by":"crossref","first-page":"14441","DOI":"10.1021\/acsnano.4c01120","article-title":"Pluronic-based nanoparticles for delivery of doxorubicin to the tumor microenvironment by binding to macrophages","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010437","article-title":"Adoptively transferred macrophages for cancer immunotherapy","volume":"13","author":"Park","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115065_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102096","article-title":"Targeting neutrophils potentiates hitchhiking delivery of drugs and agonists for postsurgical chemo-immunotherapy","volume":"54","author":"Gao","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115065_bb0490","doi-asserted-by":"crossref","first-page":"2101761","DOI":"10.1002\/adhm.202101761","article-title":"Neutrophil cyto-pharmaceuticals suppressing tumor metastasis via inhibiting hypoxia-inducible factor-1\u03b1 in circulating breast cancer cells","volume":"11","author":"Zhang","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0495","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41551-024-01180-z","article-title":"Neutrophils bearing adhesive polymer micropatches as a drug-free cancer immunotherapy","volume":"8","author":"Kumbhojkar","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115065_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10712","article-title":"Immunotherapy against glioblastoma using backpack-activated neutrophils","volume":"10","author":"Fukuta","year":"2025","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb0505","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acsnano.6b06477","article-title":"Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis","volume":"11","author":"Kang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0510","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1021\/acsnano.3c08946","article-title":"Neutrophil nanodecoys inhibit tumor metastasis by blocking the interaction between tumor cells and neutrophils","volume":"18","author":"Zeng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0515","doi-asserted-by":"crossref","first-page":"2207456","DOI":"10.1002\/advs.202207456","article-title":"Neutrophil camouflaged stealth nanovehicle for photothermal-induced tumor immunotherapy by triggering pyroptosis","volume":"10","author":"Yu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115065_bb0520","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1021\/acsnano.3c10862","article-title":"A Twindrive precise delivery system of platelet-neutrophil hybrid membrane regulates macrophage combined with CD47 blocking for postoperative immunotherapy","volume":"18","author":"Sheng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0525","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.apsb.2021.08.018","article-title":"Enhanced tumor homing of pathogen-mimicking liposomes driven by R848 stimulation: a new platform for synergistic oncology therapy","volume":"12","author":"Cheng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115065_bb0530","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.apsb.2022.06.005","article-title":"Sialic acid-mediated photochemotherapy enhances infiltration of CD8+ T cells from tumor-draining lymph nodes into tumors of immunosenescent mice","volume":"13","author":"Sui","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115065_bb0535","doi-asserted-by":"crossref","first-page":"2301835","DOI":"10.1002\/advs.202301835","article-title":"Neutrophil-mediated tumor-targeting delivery system of oncolytic bacteria combined with ICB for melanoma lung metastasis therapy","volume":"10","author":"Liu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115065_bb0540","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.2147\/IJN.S415139","article-title":"Multi-site attack, neutrophil membrane-camouflaged nanomedicine with high drug loading for enhanced cancer therapy and metastasis inhibition","volume":"18","author":"Huang","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115065_bb0545","doi-asserted-by":"crossref","first-page":"28070","DOI":"10.1021\/acsami.4c01575","article-title":"Dendritic cell immune modulation via polyphenol membrane coatings","volume":"16","author":"Janes","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115065_bb0550","doi-asserted-by":"crossref","first-page":"2420113","DOI":"10.1002\/adma.202420113","article-title":"Dendritic cell-based biohybrid immunomodulator alleviates intestinal inflammatory disease","volume":"37","author":"Yi","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0555","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2022.11.053","article-title":"Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies","volume":"353","author":"Li","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115065_bb0560","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41565-022-01098-0","article-title":"A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy","volume":"17","author":"Liu","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0565","doi-asserted-by":"crossref","first-page":"1903301","DOI":"10.1002\/advs.201903301","article-title":"Artificial mini dendritic cells boost T cell\u2013based immunotherapy for ovarian cancer","volume":"7","author":"Cheng","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115065_bb0570","first-page":"15","article-title":"Mature dendritic cell-derived dendrosomes swallow oxaliplatin-loaded nanoparticles to boost immunogenic chemotherapy and tumor antigen-specific immunotherapy","volume":"15","author":"Chen","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0575","first-page":"1","article-title":"Durable complete response to neoantigen-loaded dendritic-cell vaccine following anti-PD-1 therapy in metastatic gastric cancer","volume":"6","author":"Guo","year":"2022","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0580","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2147\/DDDT.S414758","article-title":"Dendritic cell-derived exosomes driven drug co-delivery biomimetic nanosystem for effective combination of malignant melanoma immunotherapy and gene therapy","volume":"17","author":"Lin","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jconrel.2026.115065_bb0585","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biomaterials.2015.11.001","article-title":"Super natural killer cells that target metastases in the tumor draining lymph nodes","volume":"77","author":"Chandrasekaran","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115065_bb0590","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jbm.a.37621","article-title":"TRAIL-conjugated liposomes that bind natural killer cells to induce colorectal cancer cell apoptosis","volume":"112","author":"Greenlee","year":"2024","journal-title":"J. Biomed. Mater. Res., Part A"},{"key":"10.1016\/j.jconrel.2026.115065_bb0595","doi-asserted-by":"crossref","first-page":"15918","DOI":"10.1021\/acsnano.3c03980","article-title":"Polymer micropatches as natural killer cell engagers for tumor therapy","volume":"17","author":"Prakash","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0600","doi-asserted-by":"crossref","first-page":"12096","DOI":"10.1021\/acsnano.8b05292","article-title":"Cell-membrane immunotherapy based on natural killer cell membrane coated nanoparticles for the effective inhibition of primary and abscopal tumor growth","volume":"12","author":"Deng","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0605","doi-asserted-by":"crossref","first-page":"27764","DOI":"10.18632\/oncotarget.8526","article-title":"A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2026.115065_bb0610","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm.2198","article-title":"Therapeutic cell engineering with surface-conjugated synthetic nanoparticles","volume":"16","author":"Stephan","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb0615","doi-asserted-by":"crossref","first-page":"291ra94","DOI":"10.1126\/scitranslmed.aaa5447","article-title":"Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells","volume":"7","author":"Huang","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb0620","doi-asserted-by":"crossref","first-page":"11749","DOI":"10.1021\/acsnano.3c02592","article-title":"A near-infrared-II fluorescent nanocatalyst for enhanced CAR T cell therapy against solid tumor by immune reprogramming","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0625","doi-asserted-by":"crossref","first-page":"36333","DOI":"10.1021\/acsami.9b11371","article-title":"Regulatory T cells tailored with pH-responsive liposomes shape an Immuno-antitumor milieu against tumors","volume":"11","author":"Ou","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115065_bb0630","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001097","article-title":"HITM-SURE: hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery","volume":"8","author":"Katz","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115065_bb0635","doi-asserted-by":"crossref","first-page":"2029070","DOI":"10.1080\/2162402X.2022.2029070","article-title":"T-SIGn tumor reengineering therapy and CAR T cells synergize in combination therapy to clear human lung tumor xenografts and lung metastases in NSG mice","volume":"11","author":"Sonzogni","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2026.115065_bb0640","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1007\/s12274-018-2179-5","article-title":"Cell-based drug delivery systems for biomedical applications","volume":"11","author":"Li","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2026.115065_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114136","article-title":"Leveraging macrophages for cancer theranostics","volume":"183","author":"Liu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115065_bb0650","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2019.12.001","article-title":"Drug delivery to macrophages: a review of targeting drugs and drug carriers to macrophages for inflammatory diseases","volume":"165\u2013166","author":"He","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115065_bb0655","first-page":"55","article-title":"Macrophage based drug delivery: key challenges and strategies","volume":"38","author":"Guo","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0660","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2147\/IJN.S298159","article-title":"Recent advances in macrophage-mediated drug delivery systems","volume":"16","author":"Liang","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115065_bb0665","doi-asserted-by":"crossref","first-page":"2002054","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0670","article-title":"Macrophage-centered therapy strategies: a promising weapon in cancer immunotherapy","volume":"20","author":"Wang","year":"2025","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115065_bb0675","first-page":"1","article-title":"Advances in engineered macrophages: a new frontier in cancer immunotherapy","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.115065_bb0680","doi-asserted-by":"crossref","first-page":"2503583","DOI":"10.1002\/adfm.202503583","article-title":"Differentiation responsive architected macrophage (DREAM) selectively modulate tumor microenvironment for cancer immunotherapy","volume":"35","author":"Chen","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0685","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.it.2010.05.006","article-title":"Neutrophil kinetics in health and disease","volume":"31","author":"Summers","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0690","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115065_bb0695","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.2147\/IJN.S328705","article-title":"The advances of neutrophil-derived effective drug delivery systems: a key review of managing tumors and inflammation","volume":"16","author":"Wang","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115065_bb0700","doi-asserted-by":"crossref","first-page":"2310318","DOI":"10.1002\/adma.202310318","article-title":"Engineering and targeting neutrophils for cancer therapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0705","doi-asserted-by":"crossref","first-page":"1706245","DOI":"10.1002\/adma.201706245","article-title":"Neutrophil-based drug delivery systems","volume":"30","author":"Chu","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0710","doi-asserted-by":"crossref","first-page":"1801674","DOI":"10.1002\/smll.201801674","article-title":"Neutrophil-based delivery systems for nanotherapeutics","volume":"14","author":"Han","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115065_bb0715","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1186\/s12951-024-02913-7","article-title":"Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0720","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12951-021-01110-0","article-title":"Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery","volume":"19","author":"Hao","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0725","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The role of type 1 conventional dendritic cells in cancer immunity","volume":"4","author":"B\u00f6ttcher","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2026.115065_bb0730","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00262-016-1820-y","article-title":"Tumor-derived factors modulating dendritic cell function","volume":"65","author":"Zong","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.115065_bb0735","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1021\/acs.nanolett.9b05171","article-title":"Copresentation of tumor antigens and costimulatory molecules via biomimetic nanoparticles for effective cancer immunotherapy","volume":"20","author":"Ma","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115065_bb0740","doi-asserted-by":"crossref","first-page":"1801091","DOI":"10.1002\/adhm.201801091","article-title":"Dendritic cell membrane vesicles for activation and maintenance of antigen-specific T cells","volume":"8","author":"Ochyl","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0745","doi-asserted-by":"crossref","first-page":"46222","DOI":"10.1021\/acsomega.2c04420","article-title":"Dendritic cell membrane-derived nanovesicles for targeted T cell activation","volume":"7","author":"Harvey","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2026.115065_bb0750","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41573-022-00413-7","article-title":"Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders","volume":"21","author":"Maskalenko","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115065_bb0755","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jconrel.2026.115065_bb0760","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2013.07.006","article-title":"Natural killer cell biology: an update and future directions","volume":"132","author":"Campbell","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0765","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cytogfr.2018.08.001","article-title":"Natural killer cells in inflammation and autoimmunity","volume":"42","author":"Zitti","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2026.115065_bb0770","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.3389\/fimmu.2019.02915","article-title":"NK cell metabolism and TGF\u03b2 \u2013 implications for immunotherapy","volume":"10","author":"Slattery","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0775","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/jcm9010143","article-title":"Hitting more birds with a stone: impact of TGF-\u03b2 on ILC activity in cancer","volume":"9","author":"Fionda","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb0780","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0785","doi-asserted-by":"crossref","first-page":"01090","DOI":"10.3389\/fimmu.2020.01090","article-title":"CD2 immunobiology","volume":"11","author":"Binder","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0790","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115065_bb0795","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/icb.2015.118","article-title":"The memory of a killer T cell: models of CD8+ T cell differentiation","volume":"94","author":"Gerritsen","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0800","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1021\/acsnano.0c09514","article-title":"In vivo T cell-targeting nanoparticle drug delivery systems: considerations for rational design","volume":"15","author":"Cevaal","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0805","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2016.01.044","article-title":"Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation","volume":"231","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115065_bb0810","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41598-017-00462-8","article-title":"CRISPR\/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells","volume":"7","author":"Rupp","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115065_bb0815","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41577-018-0042-2","article-title":"CAR T cells for infection, autoimmunity and allotransplantation","volume":"18","author":"Maldini","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0820","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nnano.2017.57","article-title":"In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers","volume":"12","author":"Smith","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0825","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115065_bb0830","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016980","article-title":"Exploiting endocytosis for nanomedicines","volume":"5","author":"Akinc","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101621","article-title":"Nano-drug delivery systems for T cell-based immunotherapy","volume":"46","author":"Li","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115065_bb0840","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115065_bb0845","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2012.09.038","article-title":"Cancer nanomedicines: so many papers and so few drugs!","volume":"65","author":"Venditto","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115065_bb0850","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.913287","article-title":"Toward rapid, widely available autologous CAR-T cell therapy \u2013 artificial intelligence and automation enabling the smart manufacturing hospital","volume":"9","author":"Hort","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb0855","first-page":"8052212","article-title":"Recent advances and next breakthrough in immunotherapy for cancer treatment","volume":"2022","author":"Yang","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.115065_bb0860","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1039\/D2TB00048B","article-title":"Supramolecular biomaterials for enhanced cancer immunotherapy","volume":"10","author":"Zhang","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2026.115065_bb0865","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cell.2020.03.001","article-title":"The emerging landscape of immune cell therapies","volume":"181","author":"Weber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115065_bb0870","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2217\/nnm-2019-0366","article-title":"Artificial intelligence and related technologies enabled nanomedicine for advanced cancer treatment","volume":"15","author":"Wilson","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115065_bb0875","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12645-025-00326-1","article-title":"Current state-of-the-art in multi-scale modeling in nano-cancer drug delivery: role of AI and machine learning","volume":"16","author":"Debnath","year":"2025","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0880","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12032-025-02680-x","article-title":"Smart nanomedicines powered by artificial intelligence: a breakthrough in lung cancer diagnosis and treatment","volume":"42","author":"Alavinejad","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0885","doi-asserted-by":"crossref","first-page":"1635159","DOI":"10.3389\/fimmu.2025.1635159","article-title":"Smart CAR-T nanosymbionts: archetypes and proto-models","volume":"16","author":"Baena","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0890","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.7150\/ijbs.114222","article-title":"Decoding the tumor microenvironment: exosome-mediated macrophage polarization and therapeutic frontiers","volume":"21","author":"Li","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2026.115065_bb0895","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202510239","article-title":"Artificial intelligence-driven nanoarchitectonics for smart targeted drug delivery","volume":"37","author":"Bae","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0900","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41586-026-10221-3","article-title":"Towards intelligent and miniaturized drug delivery devices","volume":"651","author":"Wei","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115065_bb0905","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1208\/s12249-025-03271-9","article-title":"Artificial intelligence in ocular drug delivery: precision drug delivery\u2019s new horizon","volume":"27","author":"Srivastava","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2026.115065_bb0910","article-title":"New frontiers in AI-nano converged platforms for intelligent diagnostics, therapeutics, and safety evaluation","author":"Zhou","year":"2026","journal-title":"Chem. Bio. Eng."},{"key":"10.1016\/j.jconrel.2026.115065_bb0915","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acsbiomaterials.5c01998","article-title":"A review on AI-based data-driven models for optimization of nanocarriers as drug delivery systems","volume":"12","author":"Kantesaria","year":"2026","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2026.115065_bb0920","doi-asserted-by":"crossref","first-page":"11121","DOI":"10.3390\/ijms262211121","article-title":"Nanomaterials in drug delivery: leveraging artificial intelligence and big data for predictive design","volume":"26","author":"Han","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115065_bb0925","doi-asserted-by":"crossref","first-page":"33288","DOI":"10.1021\/acsnano.5c09066","article-title":"TuNa-AI: a hybrid kernel machine to design tunable nanoparticles for drug delivery","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb0930","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1038\/s41467-024-55072-6","article-title":"Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115065_bb0935","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2023.07.040","article-title":"An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice","volume":"361","author":"Chou","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115065_bb0940","first-page":"11","article-title":"AI-guided nanorobots for in vivo immune cell programming: bridging nanomedicine and cancer immunotherapy, Middle East","volume":"1","author":"Mtushar","year":"2025","journal-title":"Cancer Oncol. J."},{"key":"10.1016\/j.jconrel.2026.115065_bb0945","first-page":"425","article-title":"Artificial intelligence driven protein design and sustainable nanomedicine for advanced theranostics","volume":"60","author":"Esmaeilpour","year":"2026","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0950","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1039\/C8NH00233A","article-title":"Artificial intelligence in nanomedicine","volume":"4","author":"Ho","year":"2019","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.jconrel.2026.115065_bb0955","doi-asserted-by":"crossref","first-page":"2204798","DOI":"10.1002\/adma.202204798","article-title":"Computational biomaterials: computational simulations for biomedicine","volume":"35","author":"Dai","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115065_bb0960","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s43856-023-00421-7","article-title":"Multi-resolution deep learning characterizes tertiary lymphoid structures and their prognostic relevance in solid tumors","volume":"4","author":"van Rijthoven","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb0965","article-title":"Nanotechnology-enabled diagnosis and treatment of hepatocellular carcinoma: theranostics, combination regimens, and translation","volume":"21","author":"Wang","year":"2026","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115065_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115945","article-title":"Precise metabolic dependencies of cancer through deep learning and validations","volume":"44","author":"Wu","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.115065_bb0975","doi-asserted-by":"crossref","first-page":"1067144","DOI":"10.3389\/fmedt.2022.1067144","article-title":"Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: current progress and challenges","volume":"4","author":"Das","year":"2023","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.jconrel.2026.115065_bb0980","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41592-020-01033-y","article-title":"Method of the year: spatially resolved transcriptomics","volume":"18","author":"Marx","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2026.115065_bb0985","first-page":"1","article-title":"AI-guided design of personalized nanomedicine: a review of data-driven approaches in nanoparticle formulation","volume":"7","author":"Kataria","year":"2025","journal-title":"Int. J. Multidiscip. Res."},{"key":"10.1016\/j.jconrel.2026.115065_bb0990","article-title":"Intelligent nanoparticle design: unlocking the potential of AI for transformative drug delivery","volume":"36","author":"Azimi","year":"2025","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115065_bb0995","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s42003-021-02610-3","article-title":"NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCR\u03b1 and \u03b2 sequence data","volume":"4","author":"Montemurro","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2026.115065_bb1000","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s42256-021-00383-2","article-title":"Deep learning-based prediction of the T cell receptor\u2013antigen binding specificity","volume":"3","author":"Lu","year":"2021","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.jconrel.2026.115065_bb1005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41746-022-00610-z","article-title":"Building digital twins of the human immune system: toward a roadmap","volume":"5","author":"Laubenbacher","year":"2022","journal-title":"Npj Digital Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb1010","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb1015","first-page":"1158","article-title":"LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features","volume":"5","author":"Chang","year":"2024","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.115065_bb1020","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1038\/s41467-024-52061-7","article-title":"An artificial intelligence accelerated virtual screening platform for drug discovery","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115065_bb1025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/2472630319890316","article-title":"CURATE.AI: optimizing personalized medicine with artificial intelligence","volume":"25","author":"Blasiak","year":"2020","journal-title":"SLAS Technol."},{"key":"10.1016\/j.jconrel.2026.115065_bb1030","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41467-025-68272-5","article-title":"AI-guided CAR designs and targeted pathway modulation to enhance multi-antigen CAR T cell durability and overcome antigen escape","volume":"17","author":"Ansari","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115065_bb1035","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41422-024-00936-1","article-title":"CAR-toner: an AI-driven approach for CAR tonic signaling prediction and optimization","volume":"34","author":"Qiu","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2026.115065_bb1040","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","article-title":"A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy","volume":"29","author":"Stein-Thoeringer","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115065_bb1045","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/biom15070935","article-title":"Overcoming immune barriers in allogeneic CAR-NK therapy: from multiplex gene editing to AI-driven precision design","volume":"15","author":"Kim","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2026.115065_bb1050","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.7150\/thno.94788","article-title":"Theranostics and artificial intelligence: new frontiers in personalized medicine","volume":"14","author":"Belge Bilgin","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115065_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104701","article-title":"AI-driven innovations in smart multifunctional nanocarriers for drug and gene delivery: a mini-review","volume":"210","author":"Noury","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jconrel.2026.115065_bb1060","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/17435889.2026.2661385","article-title":"Advancing nanomedicine with machine learning: predicting protein corona and nano-bio interactions","volume":"21","author":"Canchola","year":"2026","journal-title":"Nanomed"},{"key":"10.1016\/j.jconrel.2026.115065_bb1065","doi-asserted-by":"crossref","first-page":"2301838","DOI":"10.1002\/smll.202301838","article-title":"An overview of nanoparticle protein corona literature","volume":"19","author":"Hajipour","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115065_bb1070","doi-asserted-by":"crossref","first-page":"37633","DOI":"10.1021\/acsnano.5c08608","article-title":"Meta-analysis and machine learning prediction of protein corona composition across nanoparticle systems in biological media","volume":"19","author":"Canchola","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115065_bb1075","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-026-02934-1","article-title":"AI-based hematological malignancy prediction from peripheral blood smears in a large diagnostic laboratory cohort","author":"Dasdelen","year":"2026","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2026.115065_bb1080","article-title":"Artificial intelligence in hematologic malignancies: opportunities, challenges, and clinical integration","volume":"18","author":"Salem","year":"2026","journal-title":"Cureus"},{"key":"10.1016\/j.jconrel.2026.115065_bb1085","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3390\/cells14171385","article-title":"Machine learning for multi-omics characterization of blood cancers: a systematic review","volume":"14","author":"Alhamrani","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115065_bb1090","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2147\/IJN.S344208","article-title":"Predicting nanoparticle delivery to tumors using machine learning and artificial intelligence approaches","volume":"17","author":"Lin","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115065_bb1095","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1016\/j.apsb.2024.06.018","article-title":"Advancing cancer nanomedicine with machine learning","volume":"14","author":"Qin","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115065_bb1100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biomaterials.2017.06.017","article-title":"Macrophages with cellular backpacks for targeted drug delivery to the brain","volume":"140","author":"Klyachko","year":"2017","journal-title":"Biomaterials"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:42:40Z","timestamp":1787578960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":220,"alternative-id":["S0168365926004682"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115065","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune cell delivery platforms for tumor therapy: From empirical approaches to AI-integrated frameworks","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115065"}}